To test whether FHL2 inhibition can prevent proteinuria in these diseases, we introduced Adriamycin-induced FSGS model in mice and found FHL2 KO animals developed less albuminuria than their WT littermates (Supplement Fig. 2). The gene discussed is FHL2; the disease is focal segmental glomerulosclerosis.